Clinician’s Guide to cGVHD

Despite advances in transplantation techniques and immunosuppressive therapies, cGVHD remains a leading cause of non-relapse morbidity and mortality post-HSCT. Managing cGVHD requires an understanding of its heterogeneous presentation, pathophysiology, diagnostic criteria, and treatment options. This section provides curated articles on these topics.